Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
OR1J4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
METTL15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNFRSF10D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
HDAC9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GOLGA7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PCNX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KDM2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POU2AF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COX6A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM13C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101926984 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFAP69 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLHL18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MGC57346 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927826 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on